182 related articles for article (PubMed ID: 33781713)
41. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
[TBL] [Abstract][Full Text] [Related]
42. Intracavitary brachytherapy with additional Heyman capsules in the treatment of cervical cancer.
Scharl S; Hugo C; Weidenbächer CB; Bronger H; Brambs C; Kiechle M; Makowski MR; Combs SE; Schüttrumpf L
Arch Gynecol Obstet; 2023 Feb; 307(2):557-564. PubMed ID: 35639163
[TBL] [Abstract][Full Text] [Related]
43. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
[TBL] [Abstract][Full Text] [Related]
44. Technique adaptation, strategic replanning, and team learning during implementation of MR-guided brachytherapy for cervical cancer.
Skliarenko J; Carlone M; Tanderup K; Han K; Beiki-Ardakani A; Borg J; Chan K; Croke J; Rink A; Simeonov A; Ujaimi R; Xie J; Fyles A; Milosevic M
Brachytherapy; 2018; 17(1):86-93. PubMed ID: 29406125
[TBL] [Abstract][Full Text] [Related]
45. Can we reduce dose to ureters as avoidance organs for MRI based brachytherapy for cervical cancer? A dosimetric feasibility study.
Koerner SA; Baig T; Kim H; Rodríguez-López J; Keller A; Beriwal S
Brachytherapy; 2022; 21(2):202-207. PubMed ID: 34980569
[TBL] [Abstract][Full Text] [Related]
46. High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.
Vinod SK; Lim K; Bell L; Veera J; Ohanessian L; Juresic E; Borok N; Chan P; Chee R; Do V; Govindarajulu G; Sridharan S; Johnson C; Moses D; Van Dyk S; Holloway L
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):133-140. PubMed ID: 27527506
[TBL] [Abstract][Full Text] [Related]
47. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
Iwai Y; Nemoto MW; Horikoshi T; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Uno T
Jpn J Radiol; 2020 Sep; 38(9):899-905. PubMed ID: 32333219
[TBL] [Abstract][Full Text] [Related]
48. Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer.
Bell L; Holloway L; Bruheim K; Petrič P; Kirisits C; Tanderup K; Pötter R; Vinod S; Lim K; Pogson E; Metcalfe P; Hellebust TP
Brachytherapy; 2020; 19(2):146-153. PubMed ID: 32067884
[TBL] [Abstract][Full Text] [Related]
49. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
[TBL] [Abstract][Full Text] [Related]
50. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
51. Dose distribution of brachytherapy for locally advanced (stage IIB) cervical cancer.
Lin X; Wang JP; Liu ZS; Guo J; Li YF; Ren XJ; Qiu L; Wang CY; Jiang SW; Jia XJ; Wang TJ
Brachytherapy; 2020; 19(1):66-72. PubMed ID: 31837988
[TBL] [Abstract][Full Text] [Related]
52. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
[TBL] [Abstract][Full Text] [Related]
53. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis.
Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K
Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073
[TBL] [Abstract][Full Text] [Related]
54. Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size?
Yoshida K; Yamazaki H; Kotsuma T; Takenaka T; Ueda MM; Miyake S; Tsujimoto Y; Masui K; Yoshioka Y; Sumida I; Uesugi Y; Shimbo T; Yoshikawa N; Yoshioka H; Tanaka E; Narumi Y
Brachytherapy; 2016; 15(1):57-64. PubMed ID: 26612700
[TBL] [Abstract][Full Text] [Related]
55. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer.
Zhao Z; Zhang N; Liu Y; Wu N; Mao Z; Yang W; Cheng G
J Contemp Brachytherapy; 2020 Jun; 12(3):252-259. PubMed ID: 32695197
[TBL] [Abstract][Full Text] [Related]
56. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
[TBL] [Abstract][Full Text] [Related]
57. Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.
Martin DA; Taunk NK; Anamalayil S; Mangal V; Marcel J; Hubley E
J Contemp Brachytherapy; 2021 Oct; 13(5):533-540. PubMed ID: 34759978
[TBL] [Abstract][Full Text] [Related]
58. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract][Full Text] [Related]
59. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
60. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
